U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1998
116
Name Type Language
SACROSIDASE
INN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
SACROSIDASE [VANDF]
Common Name English
SACROSIDASE [ORANGE BOOK]
Common Name English
SACROSIDASE [USAN]
Common Name English
sacrosidase [INN]
Common Name English
SACROSIDASE [MI]
Common Name English
SUCRAID
Brand Name English
Sacrosidase [WHO-DD]
Common Name English
.BETA.-FRUCTOFURANOSIDASE
Common Name English
SACROSIDASE [MART.]
Common Name English
INVERTASE 2 (BETA-FRUCTOFURANOSIDASE 2, SACCHARASE, EC=3.2.1.26) FROM SACCHAROMYCES CEREVISIAE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29726
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
EU-Orphan Drug EU/3/13/1183
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
WHO-VATC QA16AB06
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
FDA ORPHAN DRUG 78693
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
NDF-RT N0000175819
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
WHO-ATC A16AB06
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
Code System Code Type Description
DRUG CENTRAL
5043
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201487
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
DRUG BANK
DB06760
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
DAILYMED
8A7F670F2Y
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
INN
10005
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
RXCUI
214817
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m9717
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C66525
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
WIKIPEDIA
SACROSIDASE
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
FDA UNII
8A7F670F2Y
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
EVMPD
SUB38353
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
USAN
JJ-47
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
CAS
85897-35-4
Created by admin on Sat Dec 16 16:52:28 GMT 2023 , Edited by admin on Sat Dec 16 16:52:28 GMT 2023
PRIMARY
ACTIVE MOIETY
SACROSIDASE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966